City of Hope

2019–2024 · research · R01

Precision approaches to refining TP53-associated cancer risk

Christopher I. Amos · City of Hope · funded by National Institutes of Health

$1.7MCancer-related Molecular Pathways

2019–2024 · research · R01

The role of O-GlcNAcylation in DNA damage repair and cancer therapy

Jeremy Michael Stark · City of Hope · funded by National Institutes of Health

$395.7kGlycosylation and Glycoproteins Research

2019–2021 · research · R21

A Novel E3 Ubiquitin Ligase for CML Stem Cells

Wenyong Chen · City of Hope · funded by National Institutes of Health

$225.8k

2019–2025 · research · R01

Exploring the preclinical relevance of therapeutic radiolabeled daratumumab (anti-CD38) in combination with anti-CS1 CAR T cells as a novel combinatorial treatment for multiple myeloma

Flavia Pichiorri · City of Hope · funded by National Institutes of Health

$394.5kCAR-T cell therapy research

2019–2024 · research · R01

Regulation of beta-cell homeostasis by DNA methylation and hydroxymethylation.

Sangeeta Dhawan · City of Hope · funded by National Institutes of Health

$432.5kPancreatic function and diabetes

2019–2024 · research · R01

Exploring the preclinical relevance of therapeutic radiolabeled daratumumab (anti-CD38) in combination with anti-CS1 CAR T cells as a novel combinatorial treatment for multiple myeloma

Flavia Pichiorri · City of Hope · funded by National Institutes of Health

$394.5kCAR-T cell therapy research

2019–2025 · research · R35

Scalable tools to effectively translate genomic discoveries into the clinic

Stacy W. Gray · City of Hope · funded by National Institutes of Health

$524.1kGenomics and Rare Diseases

2019–2024 · research · R01

Exploring the preclinical relevance of therapeutic radiolabeled daratumumab (anti-CD38) in combination with anti-CS1 CAR T cells as a novel combinatorial treatment for multiple myeloma

Flavia Pichiorri · City of Hope · funded by National Institutes of Health

$402.6kCAR-T cell therapy research

2019–2024 · cooperative agreement · U01

Optimizing GVHD Prevention with Systems Pharmacology Models

Donald E Mager · City of Hope · funded by National Institutes of Health

$600kHematopoietic Stem Cell Transplantation

2019–2024 · research · R01

Regulating SNARE mechanisms to remediate glucose homeostasis

Debbie C Thurmond · City of Hope · funded by National Institutes of Health

$432.5k

2019–2024 · research · R01

Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy

Christiane Querfeld · City of Hope · funded by National Institutes of Health

$563.7kCutaneous lymphoproliferative disorders research

2019–2024 · research · R01

Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells

Jianhua Yu · City of Hope · funded by National Institutes of Health

$423.4kImmune Cell Function and Interaction

2019–2023 · program · P20

Project 1

Dustin Edward Schones · City of Hope · funded by National Institutes of Health

2019–2024 · program · P20

Education Core

Christopher M. Sistrunk · City of Hope · funded by National Institutes of Health

2018–2025 · research · R25

Yes 2 Success

David K. Ann · City of Hope · funded by National Institutes of Health

$486k

2018–2020 · career development · K08

Mentored Clinical Scientist Research Career Development Award (Parent K08)

Thomas Paul Slavin · City of Hope · funded by National Institutes of Health

$249k

2018–2020 · research · R21

FLOAT System to Study Salivary Gland Cancer Invasion

David K. Ann · City of Hope · funded by National Institutes of Health

$216.3k

2018–2023 · training · T32

Cancer Metabolism Training Program

David K. Ann · City of Hope · funded by National Institutes of Health

$189.6kCancer, Hypoxia, and Metabolism

2018–2023 · research · R01

Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy

Steven Terry Rosen · City of Hope · funded by National Institutes of Health

$691.8kCutaneous lymphoproliferative disorders research

2018–2023 · research · R01

PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity

Defu Zeng · City of Hope · funded by National Institutes of Health

$395.9kCancer Immunotherapy and Biomarkers

2018–2023 · research · R37

Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia

Chun-Wei David Chen · City of Hope · funded by National Institutes of Health

$395.7k

2018–2024 · research · R01

Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin

Jianhua Yu · City of Hope · funded by National Institutes of Health

$374.9kVirus-based gene therapy research

2018–2023 · research · R01

Targeting protein acetylation as a therapeutic approach for MDS

Ling Li · City of Hope · funded by National Institutes of Health

$432.5k

2018–2022 · research · R01

Inflammation as determinant of clonal selection in MPN progression

Nadia Carlesso · City of Hope · funded by National Institutes of Health

$542.4kChronic Myeloid Leukemia Treatments

2018–2020 · fellowship · F99

Refinement of CAR-T-Cell therapy targeting glioblastomas

Dongrui Wang · City of Hope · funded by National Institutes of Health

$30kCAR-T cell therapy research

2018–2023 · research · R01

Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin

Jianhua Yu · City of Hope · funded by National Institutes of Health

$380.7kVirus-based gene therapy research

2018–2024 · research · R01

A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery

Jae Kim · City of Hope · funded by National Institutes of Health

$108.2k

2018–2024 · research · R01

Cell-Selective CpG-STAT3 Inhibitors for Radioimmunotherapy of Malignant Glioma

Marcin Kortylewski · City of Hope · funded by National Institutes of Health

$451.2kCytokine Signaling Pathways and Interactions

2018–2023 · research · R01

Targeting protein acetylation as a therapeutic approach for MDS

Ling Li · City of Hope · funded by National Institutes of Health

$432.5k

2018–2022 · research · R01

The function of Topoisomerase I SUMOylation in transcription and chemoresistance

Yilun Liu · City of Hope · funded by National Institutes of Health

$346kCancer therapeutics and mechanisms

2018–2022 · research · R01

DOC2B-based therapeutics for prevention/remediation of type 2 diabetes

Debbie C Thurmond · City of Hope · funded by National Institutes of Health

$432.5kPancreatic function and diabetes

2018–2028 · research · R33

Geriatric Oncology Research Infrastructure to Improve Clinical Care

William Dale · City of Hope · funded by National Institutes of Health

$631.6kFrailty in Older Adults

2018–2022 · research · R01

Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin

Jianhua Yu · City of Hope · funded by National Institutes of Health

$387.4kVirus-based gene therapy research

2018–2023 · research · R01

DOC2B-based therapeutics for prevention/remediation of type 2 diabetes

Debbie C Thurmond · City of Hope · funded by National Institutes of Health

$432.5kPancreatic function and diabetes

2018–2020 · research · R03

Defining How Mammary Adipocytes Remodel During Female Reproduction

Qiong Annabel Wang · City of Hope · funded by National Institutes of Health

$86.5k

2018–2023 · research · R01

A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery

Jae Kim · City of Hope · funded by National Institutes of Health

$706.7k

2018–2020 · grant · Standard Grant

Collaborative Research: Analysis of longitudinal multiscale data in immunological bioinformatics - Feature selection, graphical models, and structure identification

Haoquan Wu · City of Hope · funded by National Science Foundation

$34k

2018–2023 · research · R25

Yes 2 Success

David K. Ann · City of Hope · funded by National Institutes of Health

$486k

2018–2023 · training · T32

Cancer Metabolism Training Program

David K. Ann · City of Hope · funded by National Institutes of Health

$215.8kCancer, Hypoxia, and Metabolism

2018–2024 · research · R01

Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy

Steven Terry Rosen · City of Hope · funded by National Institutes of Health

$678kCutaneous lymphoproliferative disorders research